Skip to content

Seaport Therapeutics SPTX Comprehensive Income (Loss), Net of Tax, Attributable to Parent

Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies

Belden logo
BeldenBDC
$52.52M+255%
Equitable Holdings logo
Equitable HoldingsEQH
$601M-50.2%
Constellium logo
ConstelliumCSTM
$184M+283%
Allegion logo
AllegionALLE
$116.2M-37.1%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$362.26M+2,663%
Skyline Champion logo
Skyline ChampionSKY
$27.69M-25.7%

Other financials

Income statement

See full
Operating income-$27.5M-70.2%
Net income-$25.4M-93.6%
EPS (diluted)-$10.34-83.0%

Balance sheet

See full
Cash & equivalents$52.9M
Total debt$5.3M
Total equity-$115.6M-220%
Total assets$227.7M

Cash flow

See full
Operating cash flow-$20.2M+0.2%
CapEx--100%
Free cash flow-$20.2M+0.4%

Valuation

See full
Market cap$972.65M
Enterprise value$925.08M

Returns & leverage

See full
Debt / equity-0×
Current ratio13.2×

Where this comes from

Reported directly by Seaport Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.

The official record: Seaport Therapeutics ’s 10-Q, filed June 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Seaport Therapeutics 's comprehensive income (loss), net of tax, attributable to parent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Seaport Therapeutics 's comprehensive income (loss), net of tax, attributable to parent?
Seaport Therapeutics (SPTX) reported comprehensive income (loss), net of tax, attributable to parent of -$25.65M in Q1 2026.